| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.00041 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.00025 | 1 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00011 | 1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 9.6e-05 | 1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -9e-05 | 1 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -1.8e-05 | 1 |